PLoS ONE (Jan 2020)

Is reporting quality in medical publications associated with biostatisticians as co-authors? A registered report protocol.

  • Ulrike Held,
  • Klaus Steigmiller,
  • Michael Hediger,
  • Martina Gosteli,
  • Kelly A Reeve,
  • Stefanie von Felten,
  • Eva Furrer

DOI
https://doi.org/10.1371/journal.pone.0241897
Journal volume & issue
Vol. 15, no. 11
p. e0241897

Abstract

Read online

BackgroundQuality in medical research has recently been criticized for being low, especially in observational research. Methodology is increasingly difficult, but collaboration between clinical researchers and biostatisticians may improve research and reporting quality. The aim of this study is to quantify the value of a biostatistician in the team of authors.MethodsSingle-center, retrospective observational study following the STROBE reporting guidelines. We will systematically review all medical publications with biostatisticians from our center as co-authors or authors and review corresponding papers without biostatisticians from our center during the same time range. We will compare aspects of reporting quality, overall and for the three study types observational, randomized trial, and prognostic separately.DiscussionWe anticipate that the results of the study will raise awareness of the importance of high methodological quality, as well as appropriate reporting quality in clinical research.ConclusionOur study will have a direct impact on our center by making each of us more aware of the reporting guidelines for various research designs. This in turn will enhance reporting quality in future research with our involvement. Our study will also raise awareness of the important role that biostatisticians play in the design and analysis of health research projects.